Jennifer Mury, MD
Obstetrics & Gynecology · Smithfield, NCNPI 1164711388
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.6% of the total across 60 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 25 manufacturers, the largest accounting for just 13.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2024 at $277 and has fallen 54.0% since, to $127 in 2025.
Across 60 payments — averaging $17.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Astellas Pharma US Inc$148
- Exeltis, USA Inc.$115
- Coopersurgical, Inc.$112
- AbbVie$83
- Therapeuticsmd, Inc.$73
- Evofem Biosciences, Inc.$72
- plus $456 from 19 others
What the payments were for
- Consulting fees$252%
- Food & beverage$1,03398%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Astellas Pharma US Inc | 8 | $148 |
| Exeltis, USA Inc. | 7 | $115 |
| Coopersurgical, Inc. | 5 | $112 |
| AbbVie | 4 | $83 |
| Therapeuticsmd, Inc. | 5 | $73 |
| Evofem Biosciences, Inc. | 4 | $72 |
| Biogen | 3 | $57 |
| Daiichi Sankyo Inc. | 2 | $39 |
| Sage Therapeutics, LLC | 2 | $39 |
| Novo Nordisk | 2 | $36 |
| Bayer | 2 | $32 |
| Irhythm Technologies, Inc. | 1 | $32 |
| Olympus America Inc. | 2 | $27 |
| Organon | 1 | $26 |
| Duchesnay USA Incorporated | 2 | $26 |
| Dexcom, Inc. | 1 | $19 |
| Hologic Sales And Service, LLC | 1 | $17 |
| Shield Therapeutics Inc | 1 | $15 |
| Johnson & Johnson | 1 | $15 |
| Pfizer | 1 | $14 |
| Medtronic | 1 | $14 |
| Mylan Pharmaceuticals Inc. | 1 | $13 |
| Aspira Women's Health Inc | 1 | $12 |
| Avion Pharmaceuticals | 1 | $12 |
| Lupin Inc. | 1 | $11 |
How this compares
$1,058 in reported general payments places this provider in the 65th percentile of 1,344 obstetrics & gynecology providers in North Carolina.
See all obstetrics & gynecology providers in North Carolina →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Norethindrone Acetate | 12 | $1,288 |
| Estradiol | 22 | $526 |
| Medroxyprogesterone Acetate | 19 | $517 |
| ProgesteroneProgesterone, Micronized | 14 | $349 |
| Norethindrone | 11 | $294 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Smithfield
- Jerry MatkinsCharlotte$481K
- Laura McKainWilmington$475K
- Leslie Hansen-LindnerCharlotte$372K
- Robin MatthewsClyde$217K
- Haywood BrownDurham$165K
- Jack IngeRaleigh$157K
- Geeta SwamyDurham$142K
- Karie LafleurAsheville$135K
- Ty RobinsonHigh Point$114K
- Shan BiscetteCharlotte$106K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.